Commodore Capital as of Dec. 31, 2024
Portfolio Holdings for Commodore Capital
Commodore Capital holds 31 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merus N V (MRUS) | 11.9 | $163M | 3.9M | 42.05 | |
| Vaxcyte (PCVX) | 9.7 | $133M | 1.6M | 81.86 | |
| Nuvalent Inc-a (NUVL) | 9.3 | $127M | 1.6M | 78.28 | |
| Xenon Pharmaceuticals (XENE) | 7.9 | $107M | 2.7M | 39.20 | |
| Enliven Therapeutics (ELVN) | 6.9 | $95M | 4.2M | 22.50 | |
| Vera Therapeutics Cl A (VERA) | 6.1 | $83M | 2.0M | 42.29 | |
| Soleno Therapeutics (SLNO) | 5.0 | $69M | 1.5M | 44.95 | |
| Alkermes SHS (ALKS) | 4.8 | $66M | 2.3M | 28.76 | |
| Nurix Therapeutics (NRIX) | 4.1 | $57M | 3.0M | 18.84 | |
| Cogent Biosciences (COGT) | 3.9 | $54M | 6.9M | 7.80 | |
| Spyre Therapeutics Com New (SYRE) | 3.4 | $46M | 2.0M | 23.28 | |
| Miragen Therapeutics (VRDN) | 3.4 | $46M | 2.4M | 19.17 | |
| Scholar Rock Hldg Corp (SRRK) | 3.0 | $41M | 950k | 43.22 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 2.7 | $37M | 2.2M | 16.75 | |
| Pharvaris N V (PHVS) | 2.7 | $37M | 1.9M | 19.17 | |
| Mind Medicine Mindmed Com New (MNMD) | 2.2 | $30M | 4.3M | 6.96 | |
| Oruka Therapeutics (ORKA) | 2.0 | $28M | 1.4M | 19.39 | |
| Cardiff Oncology (CRDF) | 1.7 | $23M | 5.4M | 4.34 | |
| Inhibikase Therapeutics Com New (IKT) | 1.4 | $19M | 5.9M | 3.25 | |
| Neurogene (NGNE) | 1.3 | $18M | 800k | 22.86 | |
| Bright Minds Biosciences Com New (DRUG) | 1.3 | $18M | 500k | 36.02 | |
| Oric Pharmaceuticals (ORIC) | 1.2 | $16M | 2.0M | 8.07 | |
| Apogee Therapeutics (APGE) | 1.0 | $13M | 290k | 45.30 | |
| Abivax Sa Sponsored Ads (ABVX) | 0.7 | $9.4M | 1.3M | 7.32 | |
| Perceptive Cap Solutions Cor Cl A Ord Shs (PCSC) | 0.6 | $7.6M | 750k | 10.18 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 0.4 | $5.3M | 500k | 10.50 | |
| Celcuity (CELC) | 0.4 | $5.2M | 400k | 13.09 | |
| Vistagen Therapeutics Ord (VTGN) | 0.3 | $4.6M | 1.6M | 2.95 | |
| Avalo Therapeutics Com New (AVTX) | 0.3 | $3.6M | 483k | 7.43 | |
| Third Harmonic Bio (THRD) | 0.2 | $2.4M | 238k | 10.29 | |
| Nkarta (NKTX) | 0.1 | $876k | 352k | 2.49 |
